Score Your Stock

US stock · figures in US dollars · scored on full-year results

Cooper Companies The Cooper Companies, Inc.

COO · Healthcare · Medical Instruments & Supplies
Top 19% of scored stocks
OkayTop 19% of scored stocks

Cooper Companies scores 66/100 on fundamentals: in the top 19% of 503 scored S&P 500 stocks. Its strongest area is Financial Safety (83/100); its weakest is Risk (58/100).

Best
Financial 83
Weakest
Risk 58

A financially strong stock, but risk needs attention.

What looks good
What to watch
Mkt capUS$ 11.3b#483 of 503 in the S&P 500EPSUS$ 2.91P/E19.9×✓ vs sector median 30.5×P/B1.4×✓ vs sector median 4×Div yield0%Bottom 15% in the S&P 50052w range · 22% of range51.0189.83
as of 31 Oct 2026

Nearby peers

Ranks #7 of 60 in Healthcare by score

#1Universal Health Services79#5Insulet71#6Boston Scientific68
#7Cooper Companies66
#8Intuitive Surgical66#9Labcorp65

One-Minute Summary

Why Cooper Companies scores 66

A financially strong stock, but risk needs attention.

What looks good
What to watch

Business Strength

60
Why 60?
Pillar score: (0 + 1 + 2 + 1 + 2) = 6 of 10 points → 60
Return on Equity (ROE)7%Weak4-Year Revenue Growth+6%/yrOkay4-Year Profit Growth+25%/yrStrongNet Profit Margin13%OkayQuarterly Momentum+5%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +93.8%Equity ↑ +10.3%ROE % 6.8%
Net ProfitEquityROE %
294m392m375m570m7.6b8.1b8.2b8.3b202320242025TTM3.9%4.9%4.6%6.8%

Revenue & Net Profit, with Net Margin

Revenue ↑ +17.9%Net Profit ↑ +93.8%Net Margin % 13.5%
RevenueNet ProfitNet Margin %
3.6b3.9b4.1b4.2b294m392m375m570m202320242025TTM8.2%10.1%9.2%13.5%

Sales grew about 17.9% over 4 years: customers keep spending more with this company.

Profit climbed about 93.8% over 4 years: the business keeps more money as it grows.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +4.7%Net Profit ↑ +268.3%Net Margin % 40.6%
RevenueNet ProfitNet Margin %
1.0b965m1.0b1.1b1.1b1.0b1.1b1.1b118m104m88m98m85m131m-78m433mQ4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'2611.5%10.8%8.7%9.3%7.9%12.8%-7.2%40.6%
▲▲▬▼▼▲▼▲

Sales have stayed roughly flat over the last 8 quarters.

The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.

Why 83?
Pillar score: (2 + 1 + 2) = 5 of 6 points → 83
Debt-to-Equity0.3×StrongCurrent Ratio1.2×OkayInterest Coverage6.2×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt → -1%Equity ↑ +10.3%D/E 0.3×
Total DebtEquityD/E
2.6b2.6b2.5b2.5b7.6b8.1b8.2b8.3b202320242025TTM0.3×0.3×0.3×0.3×

Borrowings have stayed roughly level: manageable, as long as profits stay healthy.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +33.8%Current Liabilities ↑ +92.6%Current Ratio 1.2×
Current AssetsCurrent LiabilitiesCurrent Ratio
1.7b2.0b2.1b2.3b969m1.0b1.1b1.9b202320242025TTM1.8×1.9×1.9×1.2×
Why 63?
Pillar score: (0 + 2 + 2 + 1) = 5 of 8 points → 63
Dividend Quality0%Weak
Payout ratio: 0%
Operating Cash FlowPositive & growingStrongFree Cash FlowPositive & growingStrongCash & Cash EquivalentsPartly healthyOkay
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +70.1%Free CF ↑ +215.3%
Operating CFFree CF
608m709m796m1.0b215m288m434m678m202320242025TTM

The business generates real cash, and more of it each year: a very healthy sign.

Cash vs Total Debt

Cash ↑ +28.1%Short-Term Debt ↑ +1,313.3%Total Debt → -1%
CashShort-Term DebtTotal Debt
121m108m111m155m44m32m47m628m2.6b2.6b2.5b2.5b202320242025TTM

Dividends per Share, with Yield

DPS (cents) ↓ -100%Yield % 0%
DPS (cents)Yield %
0.81.5000202320242025TTM0%0%0%0%

Dividends were cut during this period: payouts here are not guaranteed pocket money.

Why 67?
Pillar score: (1 + 1 + 2) = 4 of 6 points → 67
P/E Ratio19.9×OkayP/B Ratio1.4×OkayPEG Ratio0.8Strong
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 84.07US$ 68.99US$ 53.91Oct '25Feb '26Jun '26Oct '26

The share price is down about 14.8% over the past year.

Why 58?
Pillar score: (2 + 1 + 2 + 1 + 1 + 0) = 7 of 12 points → 58
Earnings ConsistencySteadyStrongDebt Trend (4yr)StableOkayShare Count Trend (4yr)-1%/yrStrongInventory vs Sales (4yr)+1.8 pp/yr vs salesOkayAsset Turnover Trend (4yr)+8.5%OkayQuarterly ConsistencyLoss in 1 of 8 quartersWeak
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +17.9%Inventory ↑ +23.9%Inv. % of Rev. 21.5%
RevenueInventoryInv. % of Rev.
3.6b3.9b4.1b4.2b736m803m846m912m202320242025TTM20.5%20.6%20.7%21.5%
Ranks #7 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#5Insulet71#6Boston Scientific68
#7Cooper Companies (you)66
#8Intuitive Surgical66#9Labcorp65

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 4.2bUS$ 570.3mUS$ 1.0bUS$ 678.0mUS$ -355.3mUS$ 154.7mUS$ 2.5bUS$ 627.5mUS$ 8.3bUS$ 2.3bUS$ 1.9bUS$ 12.7bUS$ 4.3bUS$ 911.5mUS$ 0.0m7%13%0.3×1.2×6.2×-----
2025US$ 4.1bUS$ 374.9mUS$ 796.1mUS$ 433.7mUS$ -362.4mUS$ 110.6mUS$ 2.5bUS$ 47.1mUS$ 8.2bUS$ 2.1bUS$ 1.1bUS$ 12.4bUS$ 4.2bUS$ 846.0mUS$ 0.0m5%9%0.3×1.9×6.7×0%0%42.4×1.9×-
2024US$ 3.9bUS$ 392.3mUS$ 709.3mUS$ 288.1mUS$ -421.2mUS$ 107.6mUS$ 2.6bUS$ 32.2mUS$ 8.1bUS$ 2.0bUS$ 1.0bUS$ 12.3bUS$ 4.2bUS$ 802.7mUS$ 0.0m5%10%0.3×1.9×6.1×0%0%46.7×2.3×55.7
2023US$ 3.6bUS$ 294.2mUS$ 607.5mUS$ 215.0mUS$ -392.5mUS$ 120.8mUS$ 2.6bUS$ 44.4mUS$ 7.6bUS$ 1.7bUS$ 969.0mUS$ 11.7bUS$ 4.1bUS$ 735.6mUS$ 1.5m4%8%0.3×1.8×4.9×1%0%63.7×2.5×-